DMPK4BIOTECH

Masha Sergeeva, PhD, Principal

  DMPK expert proficient in drug discovery and development in various therapeutic areas experienced in advancing projects from early discovery to clinical development. Successfully implemented several IND-enabling programs, set up first-in-human doses, and analyzed clinical data.

    Combination of expertise in DMPK, Bioanalysis, Safety Assessment, and Clinical Pharmacology; good knowledge of Medicinal Chemistry.

    Experience in preparing documentation for DMPK sections of IND submissions in the following therapeutic areas: anticancer (2002, 2007), antiviral (2005, 2008), and autoimmune (2010).

Click here for a copy of Dr. Sergeeva's curriculum vitae

Click here for Dr. Sergeeva's LinkedIn profile